We also found and validated a significant dose–response relationship between the number of CHRNA3 rs1051730 T alleles and lung cancer risk (adjusted trend test P = 2.68 × 10−24 for discovery (Table 5) and adjusted trend test P = 1.82 × 10−44 for replication (Table 6)). This evidence concerns the gene CHRNA3 and lung carcinoma.